Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy

Japanese Journal of Cancer Research

Volumn 90, Issue 4, 1999, Pages 469-475

  Miyauchi, Motohiro ^a   Shimada, Hideaki ^d   Kadomatsu, Kenji ^e   Muramatsu, Takashi ^e   Matsubara, Shuichiro ^f   Ikematsu, Shinya ^g   Takenaga, Keizo ^b   Asano, Takehide ^d   Ochiai, Takenori ^d   Sakiyama, Shigeru ^c   Tagawa, Masatoshi ^a  

^a Division of Pathology   (Japan)

^b Division of Chemotherapy   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g Meiji Cell Technology Center   (Japan)

Author keywords

Esophageal cancer; Gene therapy; HSV TK; Midkine; Suicide gene

Indexed keywords

ANTIBODY; GANCICLOVIR; HEPARIN BINDING PROTEIN; MIDKINE; NEUROTROPHIC FACTOR; PRODRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DRUG SENSITIVITY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE;

EID: 0032903639     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00771.x     Document Type: Article

References (30)

1. Kadomatsu, K., Tomomura, M. and Muramatsu, T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun., 151, 1312-1318 (1988).
2. Kadomatsu, K., Huang, R., Suganuma, T., Murata, F. and Muramatsu, T. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J. Cell Biol., 110, 607-616 (1990).
3. Sekiguchi, K., Yokota, C., Asashima, M., Kaname, T., Fan, Q., Muramatsu, T. and Kadomatsu, K. Restricted expression of Xenopus midkine gene during early development. J. Biochem., 118, 94-100 (1995).
4. Michikawa, M., Kikuchi, S., Muramatsu, H., Muramatsu, T. and Kim, S. U. Retinoic acid responsive gene product, midkine (MK), has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J. Neurosci. Res., 35, 530-539 (1993).
5. Muramatsu, H., Shirahama, H., Yonezawa, S., Murata, H. and Muramatsu, T. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev. Biol., 159, 392-402 (1993).
6. Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y. and Muramatsu, T. A new family of heparin-binding growth/ differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res., 53, 1281-1285 (1993).
7. Garver, R. I., Jr., Radford, D. M., Donis-Keller, H., Wick, M. R. and Milner, P. G. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer, 74, 1584-1590 (1994).
8. Nakagawara, A., Milbrandt, J., Muramatsu, T., Deuel, T. F., Zhao, H., Cnaan, A. and Brodeur, G. M. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res., 55, 1792-1797 (1995).
9. Choudhuri, R., Zhang, H., Donnini, S., Ziche, M. and Bicknell, R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res., 57, 1814-1819 (1997).
10. O'Brien, T., Cranston, D., Fuggle, S., Bicknel, R. and Harris, A. L. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res., 56, 2515-2518 (1996).
11. Hurt, R. Surgical treatment of carcinoma of the esophagus. Thorax, 46, 526-535 (1991).
12. Aridome, K., Tsutsui, J., Takao, S., Kadomatsu, K., Ozawa, M., Aikou, T. and Muramatsu, T. Increased midkine gene expression in human gastrointestinal cancers. Jpn. J. Cancer Res., 86, 655-661 (1995).
13. Moolton, F. L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1, 279-287 (1994).
14. Tokunaga, K., Nakamura, Y., Sakata, K., Fujimori, K., Ohkubo, M., Sawada, K. and Sakiyama, S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res., 47, 5616-5619 (1987).
15. Uehara, K., Matsubara, S., Kadomatsu, K., Tsutsui, J. and Muramatsu, T. Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J. Biochem., 111, 563-567 (1992).
16. Herbomel, P., Bourachot, B. and Yaniv, M. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell, 39, 653-662 (1984).
17. Gorman, C. M., Moffat, L. F. and Howard, B. H. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol., 2, 1044-1051 (1982).
18. Miller, A. D. and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. BioTechniques, 7, 980-990 (1989).
19. Vile, R., Miller, N., Chernajovsky, Y. and Hart, I. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. Gene Ther., 1, 307-316 (1994).
20. Correll, P. H., Colilla, S. and Karlsson, S. Retroviral vector design for long-term expression in murine hematopoietic cells in vitro. Blood, 84, 1812-1822 (1994).
21. Kadomatsu, K., Hagihara, M., Akhter, S., Fan, Q.-W., Muramatsu, H. and Muramatsu, T. Midkine induces the transformation of NIH3T3 cells. Br. J. Cancer, 75, 354-359 (1997).
22. Ye, C., Qi, M., Fan, Q.-W., Ito, K., Akiyama, S., Kasai, Y., Matsuyama, M., Muramatsu, T. and Kadomatsu, K. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br. J. Cancer (1999), in press.
23. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M. and Oldfeld, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53, 83-88 (1993).
24. Vile, R. G., Nelson, J. A., Castleden, S., Chong, H. and Hart, I. R. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res., 54, 6228-6234 (1994).
25. Roth, J. A. and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89, 21-39 (1997).
26. Pedraza, R. C., Matsubara, S. and Muramatsu, T. A retinoic acid-responsive element in human midkine gene. J. Biochem., 117, 845-849 (1995).
27. Adachi, Y., Matsubara, S., Pedraza, C., Ozawa, M., Tsutsui, J., Takamatsu, H., Noguchi, H., Akiyama, T. and Muramatsu, T. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene, 13, 2197-2203 (1996).
28. Fraizer, G. C., Wu, Y. J., Hewitt, S. M., Maity, T., Ton, C. C., Huff, V. and Saunders, G. F. Transcriptional regulation of the human Wilms' tumor gene (WT1). J. Biol. Chem., 269, 8892-8900 (1994).
29. Hiltunen, M. O., Koistinaho, J., Alhonen, L., Myöhänen, S., Marin, S., Kosma, V.-M., Pääkkönen, M. and Jänne, J. Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer. Br. J. Cancer, 76, 1124-1130 (1997).
30. Silberstein, G. B., Van Horn, K., Strickland, P., Roberts, C. T., Jr. and Daniel, C. W. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proc. Natl. Acad. Sci. USA, 94, 8132-8137 (1997).